mySugr® app & Accu-Chek meters
Turn numbers into better outcomes1
Accu-Chek meters and our mySugr* app help your patients better self-manage their diabetes and provide you with the accurate data<sup>2</sup> you need to make personalised treatment decisions.
Benefits
- Effortless blood glucose (BG) logging With the mySugr app, logging BG measurements is effortless. Your patients’ Accu-Chek meter automatically transfers blood glucose readings to mySugr every time they measure their blood sugar.1
- Reliable blood glucose data Unlike manual logging, automatic data import ensures consistent and accurate BG data, eliminating errors and making sure your patients don't forget to record a BG reading.1
- Better self management for patients Patients have a complete overview of their diabetes-related data in one place, including insights on how different factors influence their BG measurements. This can empower them to make personalised treatment decisions for better therapy outcomes.1
- More efficient consultations There is little time available during each consultation. Easily accessible diabetes data and analysis give you more time for therapy optimisation discussions, resulting in more constructive consultations.
Help your patients improve their glycaemic management3
Retrospective analysis** of real-world data shows a significant improvement in diabetes management in patients with type 2 diabetes using a blood glucose meter connected to their mySugr app.3
0.44% reduction in eHbA1c3
A statistically significant reduction of 0.44% in eHbA1c was observed after 4 months of BG meter and mySugr app connectivity.3
View UK Connectivity Study
6.93% increase in measurements in range3
The percentage of measurements in range by type 2 diabetes patients increased by 6.93% with mySugr app connectivity, with increases already observed after 1 month.3
View UK Connectivity Study
Who could benefit the most?
-
Patients struggling with glucose management
- Real-world data shows the greatest improvement in eHbA1c was seen in users with with an initial eHbA1c >9%.3
-
Type 2 patients over 50 years old
- Most of the engaged mySugr users are Type 2 patients, over 50 years old, with a substantial percentage of users over 60 years old.4
-
Patients with a smartphone
- The mySugr app provides an easy-to-use experience that does not require users to be technically savvy.
Connected and Integrated
Accu-Chek Care
A platform that brings your patients’ diabetes data together, designed to support informed, personalised therapy decisions. Easily access your patients’ diabetes-relevant data – including BG, insulin and carbs – directly on Accu-Chek Care.
mySugr real world data shows improvement in diabetes management
Supporting patient engagement with digital health
How implementing digital solutions improved diabetes patient management
Connect with a representative
Do you have questions, or are you ready to see a demo? Schedule a call, and we'll show you what we can do for you, your team, and your patients.
Request demoNeed help with your patients' products?
From how-to-videos and FAQs to product manuals, our support resources are here for you and your patients every step of the way.
Product Support* mySugr app: You must be at least 18 years old to register for the Accu-Chek Account. Please see the manual for intended use.
** A retrospective analysis of 1,229 users of Accu-Chek meters connected to mySugr app with type 1 and type 2 diabetes users from the UK, who enrolled between March 2013 and May 2022, and were highly engaged (defined as ≥2 logs on at least 14 out of 30 days). Impact on eHbA1c and percentage of tests in range were calculated after 4 months of connecting the BG meters to the mobile app.
Accu-Chek Care formerly known as RocheDiabetes Care Platform.
The Accu-Chek FastClix finger pricker is intended for patient self-monitoring by an individual person only. It must not be used to collect blood in a multipatient setting as it does not incorporate any features to guard against cross infection.
References
1. Debong F, Mayer H, and Kober J. Real-World Assessments of mySugr Mobile Health App. Diabetes Technol Ther. 2019;21(S2):S235– S240.
2. Breitenbeck N, Brown A. Accuracy Assessment of a Blood Glucose Monitoring System for Self-Testing with Three Test Strip Lots Following ISO 15197:2013/EN ISO 15197:2015. J Diabetes Sci Technol. 2017 Jul;11(4):854-855.
3. Ide C, et al. Real World Data analysis shows a significant improvement in glycaemic management when using a blood glucose monitor connected with a mobile health application in UK users with Type 2 Diabetes. Diabetes UK Professional Conference Poster Session, Liverpool, 26-28 Apr 2023, Poster 19
4. Roche Diabetes Care: mySugr app analytics, 2022. Data on file.
BGM easier (Accu-Chek Instant Target Range Indicator): Parkin CG, et al. Use of an Integrated Tool for Interpretation of Blood Glucose Data Improves Correctness of Glycemic Risk Assessment in Individuals with Type 1 and Type 2 Diabetes. J Diabetes Sci Technol. 2016 Sep 12.
UK version of mySugr real world evidence: Ide C, et al. Real World Data analysis shows a significant improvement in glycaemic management when using a blood glucose monitor connected with a mobile health application in UK users with Type 2 Diabetes. Diabetes UK Professional Conference Poster Session, Liverpool, 26‑28 Apr 2023, Poster 198
Virtually pain-free: Jendrike N et al. Pain sensation at Fingertips and Palm by using different Blood Glucose Monitoring Systems. Diabetes Technology Meeting. San Francisco, 5-7 November 2009.